Prognosis of primary papillary Ta-G3 bladder cancer in the non-muscle invasive spectrum

MLA

I.J. Beijert, et al. “Prognosis of Primary Papillary Ta-G3 Bladder Cancer in the Non-Muscle Invasive Spectrum.” European Urology Open Science, vol. 45, Nov. 2022, pp. S48–50. EBSCOhost, https://doi.org/10.1016/s2666-1683(22)02453-3.

APA

I.J. Beijert, A.E. Hentschel, J. Bründl, E.M Compérat, K. Plass, O. Rodríguez, J.D. Subiela Henríquez, V. Hernández, E. De La Peña, I. Alemany, D. Turturica, F. Pisano, F. Soria, O. Čapoun, L. Bauerová, M. Pešl, H.M. Bruins, W. Runneboom, S. Herdegen, … B.W.G. Van Rhijn. (2022). Prognosis of primary papillary Ta-G3 bladder cancer in the non-muscle invasive spectrum. European Urology Open Science, 45, S48–S50. https://doi.org/10.1016/s2666-1683(22)02453-3

Chicago

I.J. Beijert, A.E. Hentschel, J. Bründl, E.M Compérat, K. Plass, O. Rodríguez, J.D. Subiela Henríquez, et al. 2022. “Prognosis of Primary Papillary Ta-G3 Bladder Cancer in the Non-Muscle Invasive Spectrum.” European Urology Open Science 45 (November): S48–50. doi:10.1016/s2666-1683(22)02453-3.